Although in vitro and in vivo antibody experiments made the contribution of sLea unlikely [28, 30, 33, 102], in vivo PM formation from pancreatic cancer was inhibited after decreasing sLex and sLea biosynthesis by blocking fucosyltransferase 3 (FUT3) [107]. This evidence concerns the gene FUT3 and familial pancreatic carcinoma.